Page last updated: 2024-10-30

leflunomide and Canine Diseases

leflunomide has been researched along with Canine Diseases in 5 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research Excerpts

ExcerptRelevanceReference
"To evaluate efficacy and adverse effects of leflunomide for the treatment of naturally occurring immune-mediated polyarthritis (IMPA) in dogs."7.76Efficacy of leflunomide for treatment of immune-mediated polyarthritis in dogs: 14 cases (2006-2008). ( Baker, TA; Colopy, SA; Muir, P, 2010)
"To evaluate efficacy and adverse effects of leflunomide for the treatment of naturally occurring immune-mediated polyarthritis (IMPA) in dogs."3.76Efficacy of leflunomide for treatment of immune-mediated polyarthritis in dogs: 14 cases (2006-2008). ( Baker, TA; Colopy, SA; Muir, P, 2010)
" Data that were extracted from the medical records included signalment, body weight, underlying indication for leflunomide, dosage of leflunomide, treatment duration, concurrent medications, treatment response, and adverse events."1.46A Retrospective Study on the Safety and Efficacy of Leflunomide in Dogs. ( Lappin, MR; Legare, M; Sato, M; Veir, JK, 2017)
"The leflunomide treatment response rate was 93."1.43Efficacy of leflunomide for treatment of refractory inflammatory colorectal polyps in 15 Miniature Dachshunds. ( Eguchi, N; Fukushima, K; Igarashi, H; Kanemoto, H; Nakashima, K; Ohmi, A; Ohno, K; Takahashi, M; Tsujimoto, H, 2016)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Tani, A1
Seno, T1
Yokoyama, N1
Nakagawa, T1
Tomiyasu, H1
Goto-Koshino, Y1
Tsujimoto, H2
Ohno, K2
Sato, M1
Veir, JK1
Legare, M1
Lappin, MR1
Fukushima, K1
Eguchi, N1
Kanemoto, H1
Takahashi, M1
Igarashi, H1
Ohmi, A1
Nakashima, K1
Colopy, SA1
Baker, TA1
Muir, P1
Gregory, CR1
Stewart, A1
Sturges, B1
DeManvelle, T1
Cannon, A1
Ortega, T1
Harb, M1
Morris, RE1

Other Studies

5 other studies available for leflunomide and Canine Diseases

ArticleYear
Comparison of the efficacy of cyclosporine and leflunomide in treating inflammatory colorectal polyps in miniature dachshunds.
    The Journal of veterinary medical science, 2020, Apr-09, Volume: 82, Issue:4

    Topics: Animals; Colonic Polyps; Cyclosporine; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Japan;

2020
A Retrospective Study on the Safety and Efficacy of Leflunomide in Dogs.
    Journal of veterinary internal medicine, 2017, Volume: 31, Issue:5

    Topics: Animals; Dog Diseases; Dogs; Female; Immune System Diseases; Immunosuppressive Agents; Isoxazoles; L

2017
Efficacy of leflunomide for treatment of refractory inflammatory colorectal polyps in 15 Miniature Dachshunds.
    The Journal of veterinary medical science, 2016, Volume: 78, Issue:2

    Topics: Animals; Colonic Polyps; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Intestinal Polyps; Is

2016
Efficacy of leflunomide for treatment of immune-mediated polyarthritis in dogs: 14 cases (2006-2008).
    Journal of the American Veterinary Medical Association, 2010, Feb-01, Volume: 236, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Autoimmune Diseases; Dog Diseases; Dogs

2010
Leflunomide effectively treats naturally occurring immune-mediated and inflammatory diseases of dogs that are unresponsive to conventional therapy.
    Transplantation proceedings, 1998, Volume: 30, Issue:8

    Topics: Aniline Compounds; Animals; Crotonates; Dog Diseases; Dogs; Female; Hydroxybutyrates; Immune System

1998